Latest Private Equity & Venture Capital News

An Auckland private equity firm is backing a Sydney company which is focusing on recovering and recycling waste as an alternative to sending it to landfill.

An ASX-listed company has agreed to provide initial due diligence access to a US-based private equity suitor after the firm lifted its offer to $2.134 billion.

Australian superannuation funds have invested in a $660 million continuation fund raised by a global intrastructure investor to support the growth of an Australia-founded energy transition-focused international mass transit systems operator.

ASX-listed petroleum fuels business Ampol is to pay $225 million to acquire a leading privately-owned electrical vehicle charging business.

A due diligence company used by leading Australian private equity firms has been acquired by a big four commercial services firm.

A Sydney private equity firm is to exit its long-held stake in a New Zealand health care business with the company to be sold to investors including an Auckland private equity firm.

A venture firm has led a $6 million investment round in a company that is building a market for software that manages image-based data on the condition of physical infrastructure.

A private equity firm has invested in the merger of a technology investee with a consulting firm that specialises in cybersecurity protection.

Land-lease communities operator Ingenia (ASX: INA) is considering a further revised private capital acquisition offer which imposes a tight time limit on conditional agreement.

A private capital-backed international clinical trials business is to acquire an Australian bioanalytic research business for $160 million.

A Sydney venture capital firm has contributed to a $US200 million funding round for a US space tech company.

An international student recruitment business has rejected a $695.8 million acquisition offer from a global private capital firm describing it as opportunistic.

An Australian venture firm has led overseas investors in a $483 million round which will accelerate commercialisation of Melbourne-developed medical scribe technology.

A global investment manager has led the latest fundraising round for a Melbourne-based renewable energy provider as the company steps up expansion in Europe.

An ASX-listed financial services company has rejected a $2.6bn further revised acquisitoin offer from a global private capital company sending its shares down more than 15%.

An ASX-listed company has rejected a revised $2 billion acquisition offer from a New York private equity firm.

A New Zealand govenrment-backed fund-of-funds has reduced its allocation to a Silicon Valley fund which has reached the end of its investment term with significant funding still to invest.

Existing and new investors have provided $8.6 million in funding to a medical technology company that is progressing toward commercialisation of an automated system to take high quality ultrasound images for use in the treatament of vascular conditions.